GSK plc (GSK) short interest & options flow
NYSEGSK Jefferies downgrade cuts price target to 55.9 from 67.4, rating slashed to Hold from Buy. Stock at 48.68, down 4.9% over past week. Short interest up 14% in past month.
- Market cap
- $99.40B
- Next earnings
- 3 Feb 2027
Key data as of 3 Nov 2026

Latest signals on GSK
- Analyst
GSK Jefferies downgrade cuts price target to 55.9 from 67.4, rating slashed to Hold from Buy. Stock at 48.68, down 4.9% over past week. Short interest up 14% in past month.
GSK news and analysis
RSSNo long-form analysis yet for GSK. Pulse alerts and the live data picture are available on ORTEX.
Open GSK on ORTEX →Want the live picture for GSK?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for GSK — free to start on ORTEX.
Sign up for free →Open GSK on ORTEX